SonoSite and ATL pair ultrasound system sales

Article

ATL Ultrasound will be able to bundle sales of the SonoSite 180 handheld ultrasound system with its own ultrasound systems, thanks to a contract revision signed this month.The agreement removes an exclusivity provision of a January 1999 contract and

ATL Ultrasound will be able to bundle sales of the SonoSite 180 handheld ultrasound system with its own ultrasound systems, thanks to a contract revision signed this month.

The agreement removes an exclusivity provision of a January 1999 contract and enables ATL, a Philips Medical Systems company, to include the SonoSite 180 system with sales of its ultrasound systems. In addition, it allows SonoSite to sell products to private offices as well as hospitals.

The agreement was necessary because SonoSite restructured a distribution contract with PSS World Medical that was signed last year. SonoSite struck an exclusive distributor agreement with PSS World Medical subsidiary Diagnostic Imaging for SonoSite 180 in the private-practice market (SCAN 8/4/99).

ATL produces a line of ultrasound machines called HDI, for high definition imaging, while SonoSite develops, sells, and manufactures a 5-pound handheld digital ultrasound system. The SonoSite 180 system was developed using licensed ATL technology and part of the SonoSite system is manufactured by ATL, said Tim Mickelson, president and CEO of ATL Ultrasound.

The 19 member countries of NATO will purchase the SonoSite 180 handheld ultrasound system for use on the battlefield (SCAN 4/12/00).

SonoSite and ATL Ultrasound signed a similar agreement in March of this year giving ATL exclusive rights to include SonoSite's SonoHeart handheld echocardiology device with sales of its own HDI ultrasound systems and with cardiac catheterization systems from Philips Medical Systems. The SonoHeart agreement covers the distribution of products in cardiology-related segments worldwide, with the exception of Japan. Distribution in Japan is covered under an agreement with Olympus Optical.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.